文献速递功能神经外科

三次及以上伽玛刀放射外科治疗复发三叉神经痛的结果

Results of three or more Gamma Knife radiosurgery procedures for recurrent trigeminal neuralgia.
PubMed 文献 · J Neurosurg · 2021-04-23

多中心回顾性分析1997年7月至2019年4月两家机构中至少接受三次伽玛刀放射外科治疗的30例三叉神经痛患者,第三次治疗后93.1%获完全或部分疼痛缓解,中位随访39个月时77%维持缓解,29%出现新发或进展性面部感觉障碍。

要点

  • 第三次伽玛刀后疼痛缓解时间较前延长(p=0.0003),复发时间各次间相似(p=0.842)。
  • 第三次治疗后完全或部分缓解率93.1%,中位随访39个月时77%维持缓解。
  • 第三次治疗后29%出现新发或进展性面部感觉障碍,14%报告为困扰。

核心结论

  • 作者描述了迄今最大系列的接受三次及以上伽玛刀放射外科治疗难治性三叉神经痛的患者,第三次治疗在长期疼痛缓解、复发和不良反应方面可能产生与前两次相似的结果。

研究设计与样本

  • 多中心回顾性分析,纳入1997年7月至2019年4月在两家机构接受至少三次伽玛刀放射外科治疗的三叉神经痛患者,共30例(女16例,男14例)。

主要发现

  • 首次伽玛刀治疗前中位疼痛持续时间为10年,3例(10%)患多发性硬化。
  • 第三次治疗后疼痛缓解时间较前延长(p=0.0003),而疼痛复发时间在各次连续治疗间相似(p=0.842)。
  • 第三次治疗后93.1%的患者获完全或部分疼痛缓解,无既往经皮手术史者(p=0.0111)及伽玛刀治疗前疼痛持续时间较短者(p=0.0449)第三次治疗后最大疼痛缓解显著更好。
  • 第三次伽玛刀治疗后29%出现新发或进展性面部感觉障碍,14%报告为困扰;1例出现面部抽动,另1例持续流泪,未发现第三次治疗后不良反应的统计学显著预测因素。
  • 中位随访39个月期间77%的患者维持完全或部分疼痛缓解;3例接受第四次伽玛刀治疗,其中1例最终接受五次治疗,均在延长随访中报告持续疼痛缓解。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Gamma Knife radiosurgery (GKRS) is an established surgical option for the treatment of trigeminal neuralgia (TN), particularly for high-risk surgical candidates and those with recurrent pain. However, outcomes after three or more GKRS treatments have rarely been reported. Herein, the authors reviewed outcomes among patients who had undergone three or more GKRS procedures for recurrent TN. METHODS: The authors conducted a multicenter retrospective analysis of patients who had undergone at least three GKRS treatments for TN between July 1997 and April 2019 at two different institutions. Clinical characteristics, radiosurgical dosimetry and technique, pain outcomes, and complications were reviewed. Pain outcomes were scored on the Barrow Neurological Institute (BNI) scale, including time to pain relief (BNI score ≤ III) and recurrence (BNI score > III). RESULTS: A total of 30 patients were identified, including 16 women and 14 men. Median pain duration prior to the first GKRS treatment was 10 years. Three patients (10%) had multiple sclerosis. Time to pain relief was longer after the third treatment (p = 0.0003), whereas time to pain recurrence was similar across each of the successive treatments (p = 0.842). Complete or partial pain relief was achieved in 93.1% of patients after the third treatment. The maximum pain relief achieved after the third treatment was significantly better among patients with no prior percutaneous procedures (p = 0.0111) and patients with shorter durations of pain before initiation of GKRS therapy (p = 0.0449). New or progressive facial sensory dysfunction occurred in 29% of patients after the third GKRS treatment and was reported as bothersome in 14%. One patient developed facial twitching, while another experienced persistent lacrimation. No statistically significant predictors of adverse effects following the third treatment were found. Over a median of 39 months of follow-up, 77% of patients maintained complete or partial pain relief. Three patients underwent a fourth GKRS treatment, including one who ultimately received five treatments; all of them reported sustained pain relief at the extended follow-up. CONCLUSIONS: The authors describe the largest series to date of patients undergoing three or more GKRS treatments for refractory TN. A third treatment may produce outcomes similar to those of the first two treatments in terms of long-term pain relief, recurrence, and adverse effects.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Gupta M, Sagi V, Mittal A, et al. Results of three or more Gamma Knife radiosurgery procedures for recurrent trigeminal neuralgia. J Neurosurg. 2021. PMID: 34852325. doi:10.3171/2020.10.JNS202323

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。